Abstract The proceedings of the workshop synthesize the experimental, preclinical, and clinical data suggesting that the cerebellum, basal ganglia (BG), and their connections play an important role in pathophysiology of various movement disorders (like Parkinson's disease and atypical parkinsonian syndromes) or neurodevelopmental disorders (like autism). The contributions from individual distinguished speakers cover the neuroanatomical research of complex networks, neuroimaging data showing that the cerebellum and BG are connected to a wide range of other central nervous system structures involved in movement control. Especially, the cerebellum plays a more complex role in how the brain functions than previously thought.
in time encoding, most experiments showed that they played different roles, such as encoding short versus long time intervals, dealing with explicit versus implicit timing or addressing timing versus temporal order [3, 4] . Many everyday skills, such as sports and the operation of motor vehicles or machinery require precise timing [5] ; neurological disorders that disrupt motor timing lead to dysmetric or inaccurate movements [6, 7] . Movements involve changes in muscle length over time, thus motor control and timing are inextricably related [8] .
The proceedings of the workshop CEREBELLUM, BASAL GANGLIA AND CORTICAL CONNECTIONS UNMASKED IN HEALTH AND DISORDER held in Brno, Czech Republic on October 17th, 2013; synthesize the experimental, preclinical and clinical data suggesting that the cerebellum, BG and their connections play an important role in pathophysiology of various movement disorders (like Parkinson's disease, atypical parkinsonian syndromes) or neurodevelopmental disorders (like autism). The contributions from individual distingushed speakers cover the neuroanatomical research of complex networks, neuroimaging data showing that the cerebellum and BG are connected to a wide range of other central nervous system structures involved in movement control. Especially the cerebellum plays a more complex role in how the brain functions than previously thought [9] .
Cerebellar-Basal Ganglia Communication: Physiological Evidence of a Fast Route for Interaction (Michaela Loft, Stella Koutsikou, Nadia Cerminara and Richard Apps)
The cerebellum is involved in a diverse array of functions, ranging from motor control (for review see [10] ) to higher cognitive abilities e.g. language [11] . Given its uniform cytoarchitecture, it is generally thought that this functional diversity arises predominantly from regional differences in afferent and efferent connections. Inputs to the cerebellum have been described in considerable detail (e.g. [12] ). In particular, climbing fibre afferents, which originate exclusively from the inferior olive, have been shown to be highly topographically organized, with specific olivary subregions providing climbing fibres that terminate in longitudinally arranged cortical zones of Purkinje cells with distinct phenotype [12] . Some alignment between mossy fibre and climbing fibre projections has also been found (e.g. [13] ). In turn, Purkinje cells located within each zone provide a highly convergent projection to specific regions of the cerebellar and vestibular nuclei that also receive climbing fibre collaterals that terminate in the same zone [14] .
By comparison, much less is known about the organisation of cerebellar nuclear outputs to other parts of the CNS. However, a major target is the thalamus. From there, projections are sent to cerebral structures e.g. motor cortex. In turn, the cerebral cortex sends projections to pre-cerebellar nuclei, thereby forming multiple 'cortico-cerebellar' loops, reminiscent of cortico-basal ganglia loops (e.g. [15] ). Despite these similarities in organization, the cortico-basal ganglia and cortico-cerebellar loops are thought to operate largely independently. This is because basal ganglia and cerebellar outputs terminate in mainly separate thalamic territories [16] [17] [18] , which subsequently project to different layers of the cerebral cortex [17] . However, recent studies have challenged this view, reporting an anatomical connection between the cerebellar dentate nucleus (DN) and the striatum via the centrolateral (CL) thalamus in both rodents and primates [19] [20] [21] . Presently, nothing is known about the functional significance of this connection.
As a first step towards addressing this question, we have investigated the physiology of the pathway, to determine whether it is a reliable route for communication; and whether the cerebellar projection influences all regions of the striatum or only discrete areas. Recordings were made in urethane (1.4 mg/kg i.p) and ketamine/xylazine (25 mg/kg and 2.5 mg/kg i.p) anaesthetised rats (n=6) with the aim of mapping the location of neuronal responses in the striatum evoked by contralateral cerebellar DN stimulation. Evoked field potentials were recorded across the dorsal-ventral extent of the striatum at three medio-lateral co-ordinates relative to midline (2.5 mm, 3.5 mm and 4.0 mm lateral to bregma). Stimulation of DN (single pulses, 0.2 ms duration, inter pulse interval 3 s, mean current strength 180 μA) evoked a localised field potential in the striatum with a mean onset latency of 4.1 ms and a peak latency of 7.4 ms. Onset latencies did not vary with recording position (p=0.84; Kruskal-Wallis with Dunn's posttest).
Amplitude of the evoked field potential varied as both a function of medio-lateral and dorsal-ventral recording position (Fig. 1a) . The evoked field potentials in the dorsolateral striatum were significantly larger than evoked fields recorded in any other striatal region (Fig. 1b, p<0 .001; Kruskal-Wallis with Dunn's post-test).
Given the extensive interconnectivity between the cerebellum and the cerebral cortex, and the basal ganglia and the cerebral cortex, there is a possibility that the evoked field potentials were either a far field generated in the cerebral cortex, or genuinely localised in the striatum, but mediated via a dentate-thalamo-cerebral cortical-striatal pathway rather than a more direct dentate-thalamo-striatal projection. To address this issue, recordings were also made from the overlying cerebral cortex. In every experiment the evoked field potentials in the cerebral cortex were smaller in amplitude than those in the dorsal striatum. Moreover, the onset latency of evoked fields in the cerebral cortex was not significantly different from those recorded in the striatum. Taken together these results are therefore consistent with the recorded striatal responses being due to transmission via a subcortical route from cerebellum to striatum (presumably via the thalamus) rather than a product of cerebral cortical activity.
A small sample of single units (n=3) were also recorded in the striatum in response to single pulse stimulation of the contralateral DN. Each unit showed a brief, shortlatency excitation in response to DN stimulation with a high probability of occurrence. The latencies of the responses ranged from 5.9-7.6 ms, with a mean latency of 6.7 ms (Fig. 1c) .
In conclusion these data reveal that a powerful, short latency pathway connects the DN with the dorsolateral striatum in the rat. The dorsolateral striatum is known to be involved in habit formation [23] , raising the possibility that the cerebellum plays an important role in modifying basal ganglia activity associated with habitual behaviour. Magnetic Resonance Diffusion Tensor Imaging (DTI) is a method to visualize brain white matter in humans in a noninvasive way. DTI has been applied to detect structural changes of white matter in healthy subjects from childhood to adulthood [24] and in patients with several diseases, including schizophrenia [25] . Due to the non-invasive feature of the method, changes in white matter might be followed over the course of the disease or in some instances even prior to symptom onset. This is of special interest to diseases such as Fig. 1 a) Topography of evoked striatal responses to contralateral dentate (DN) stimulation. Schematic diagram of a transverse section through the striatum (adapted from [22] ). The striatum was subdivided into 4 regions dorso-ventrally. Evoked potentials recorded in the same subdivision were pooled for analysis. The three medio-lateral recording tracks are shown as dashed vertical lines. Waveform averages of evoked striatal field potentials in a single example case. Waveform averages were generated from 10 consecutive evoked field potentials. The evoked field potentials were largest in the most dorsolateral recording locations, and smallest in more ventromedial recording locations. For each trace an arrow indicates the stimulus onset. b) Changes in field potential amplitude as a function of medio-lateral and dorsoventral recording position. Bar graph shows pooled mean peak to trough amplitude of evoked striatal fields in each track for all 4 striatal subdivisions (n=6 animals). Peak to trough amplitude was normalised to the largest response for each case. On average the largest response was found in the dorsolateral striatum (dorsal striatum, yellow bars, compared across mediolateral recording sites i.e. Sagittal cerebellar section (adapted from [22] ) showing three schematics of the DN at different medio-lateral co-ordinates. The black filled circles indicate the location of the stimulating electrode in the contralateral DN. In all 6 animals the electrode tip was found to be within the anatomical boundaries of the dentate nucleus.
schizophrenia, where changes in white matter prior to symptom onset have been reported, and suggested to reflect increased risk to develop psychosis.
To characterize structural abnormalities of white matter one has to reflect upon two features of those changes; namely their location, and biological nature. Those features of white matter pathology are not only disease specific, but can even change during the course of the disease. The DTI method is sensitive to subtle changes in the diffusion properties of water molecules in tissue. The outcome measures of DTI include fractional anisotropy (FA, which describes directionality of the diffusion), Mean Diffusivity (MD, average diffusion in all directions), axial diffusivity (AD, diffusion along the direction of the axon) and radial diffusion (RD, diffusion perpendicular to the axon). When images of patients are compared to healthy subjects, typically, in chronic schizophrenia patients the FA value decreases and RD increases, which is thought to reflect abnormalities in the microstructure of the axon and is interpreted as abnormalities of the myelin sheath [26, 27] . It has been recently speculated that at the time of first episode of psychosis, decreases in FA and increases in MD might point to a different scenario, to an acute and reversible inflammatory process [28] . Prior to the onset of psychosis, white matter changes have been also reported in subjects with increased clinical [29] , as well as genetic risk for schizophrenia. The genetic risk has been explored in siblings of schizophrenics, as well as in subjects with 22q11.2 deletion syndrome that have a 30 % incidence of schizophrenia in adulthood. The later population has been characterized by reductions in FA and in AD, which presumably reflect changes of white matter, which might be interpreted as developmental abnormalities at the level of the axon [30, 31] . The nature of these DTI abnormalities (lack of either RD or MD changes) suggests intact myelin and lack of neuroinflammation at this stage.
The localization of the changes might be explored either by comparing whole brain white matter (using Voxel Based Morphometry, VBM, or Tract-Based Spatial Statistics, TBSS) or by performing tractography to reconstruct specific white matter tracts from DTI data. In schizophrenia the localization of the changes has not been established yet despite close to twohundred of DTI studies being performed so far. Although a meta-analysis reports mostly changes to fronto-temporal connections [32] , other summaries of DTI studies favor the view that changes are scattered all over the brain [33, 34] . The lack of the consensus of the localization is unexpected at the first glance, but might be explained by the heterogeneity of clinical presentations of patient group in each study. Schizophrenia is diagnosed by a number of symptoms, like hallucinations, delusions, disorganized speech or negative symptoms and may therefore comprise disorders with different trajectories. Thus, the data set of each study is as heterogeneous as the patients' symptoms and the diverse areas impacted. Indeed, studies dividing schizophrenia patients into subgroups based either on symptoms, genetics, Research Domain Criteria (RDoc), hallucinations or movement deficits [35] are promising approaches to explore whether in a homogenous patient population the symptoms will be associated with changes localized to specific white matter tracts.
Is DTI a suitable method to explore white matter connections between the cerebellum, the basal ganglia and the cortex? Images acquired on scanners with magnetic fields of 1.5 and 3 Tesla allow the reconstruction of about 17 fiber tracts [36] , including three cerebellar tracts, such as the superior cerebellar peduncle (scp), the middle cerebellar peduncle (mcp) and the inferior cerebellar peduncle (icp) (Fig. 2) , but none of the specific tracts of basal ganglia. Connections to and from the basal ganglia are extensive and due to the small size of the subnuclei (few mm in diameter) the reconstruction of the individual tracts requires image resolution higher than 1 mm x 1 mm x 1 mm, a better resolution than most of the DTI acquisitions using scanners of 3 Tesla can offer today. Sophisticated image post-processing methods such as multi-tensor tractography, as opposed to the most commonly used streamline tractography, were applied to explore corticostriatal connections on 3 Tesla data [37] , but so far only few studies were successful.
Are connections between the cerebellum, basal ganglia and neocortex abnormal in schizophrenia? It is very likely that they are: abnormal corticostriatal connections [37] and abnormal connectivity in cerebellar tracts, structural as well as functional, were reported in schizophrenia patients [35, 38, 39] . So far, only few DTI studies have addressed these connections. One reason is that most of the schizophrenia studies have focused on cortical connections and not cerebellum. The second reason, as mentioned above, is that reconstruction of these specific connections in vivo poses technical challenges so far. Advances in imaging methods, either scanning at higher magnetics fields (7 Tesla) or improvement of acquisition techniques and image post-processing methods will allow the reconstruction of these tracts in the very near future.
Imaging of the Cerebellar Nuclei in Health and Disease (Dagmar Timmann)
Deep cerebellar nuclei have rarely been assessed in human studies. Recent studies of our group focused on structural and functional magnetic resonance imaging (MRI) of the dentate nuclei in humans. Iron-content of the dentate nuclei is high. The paramagnetic effect of iron is used to visualize the dentate nuclei as hypointensities in susceptibility weighted images (SWI) [40] . One future application is to quantify the volume of cerebellar nuclei in patients with degenerative cerebellar disease. This is of particular interest in disorders which have known atrophy of the cerebellar nuclei based on histological data. The best known examples are spinocerebellar ataxia type 3 (SCA3) and Friedreich's ataxia (FRDA) [41] . In a first study, we were able to show atrophy of cerebellar nuclei in patients with FRDA based on SWI images [42] . Because there is no or little degeneration of the cerebellar cortex, standard diagnostic MRI scans frequently show no cerebellar abnormality in FRDA.
Another application of SWI imaging is to determine the relationship between behavioral abnormalities and the location of lesions of the cerebellar nuclei. In patients with focal cerebellar lesions, for example due to stroke, SWI allows to perform lesionsymptom mapping on the level of the dentate nuclei. Here, lesions are outlined within the dentate nuclei [43] . The same region-ofinterest-(ROI)-driven normalization technique is used to perform lesion-symptom-mapping, which had initially been developed by Diedrichsen et al. [40] for functional MRI of the dentate nuclei. In a first study, we were able to show that more dorsal and rostral parts of the dentate nuclei were related to upper limb ataxia [43] . Findings are in good accordance with the dentate hand area shown in recent fMRI studies of our group and anatomical data in monkey discussed below. As yet, in most human cerebellar lesion studies high resolution T1-weighted MR images are available, but not SWI. Cerebellar nuclei are commonly not visible on T1-weighted images. However, some conclusions can still be drawn on the level of the cerebellar nuclei. Lesions are drawn on the T1-weighted images and include cerebellar cortex and nuclei to various extents. Normalized lesions are superimposed on cerebellar atlas templates which include the cerebellar nuclei, for example the most recent version of the probabilistic atlas template of the cerebellum developed by Joern Diedrichsen [40, 44] . Using this approach Winfried Ilg's and our group were able to show that lesions of the posterolateral hemispheres and the dentate nuclei lead to abnormal treatmill tandem gait. Lesions of the medial cerebellum and interposed nuclei, on the other hand, are related to abnormal treatmill walking [45] .
On a structural level, dentate nuclei can be visualized using conventional (1.5 T, 3 T) and ultra-high-field (7 T) MRI. Increasing field strength leads to better spatial resolution [43] . On a functional level, it is difficult to achieve robust activations of the dentate nuclei using conventional field strength. Ultrahigh-field MRI together with optimized region-of-interest (ROI)-based normalization methods allow for reliable functional MRI studies at the level of the dentate nuclei [40] . We found evidence of a motor somatotopy within the human dentate nuclei [46] . In subsequent studies we were able to show that different areas within the dentate nuclei contribute to motor and cognitive tasks (verb generation and verbal working memory) [47, 48] . Findings are consistent with Peter Strick's anatomical data in the monkey. His group observed a motor domain within the dorso-rostral parts of the dentate nucleus and a non-motor domain within its ventro-caudal parts [49] . In an ongoing study we investigate different patterns of activations within the cerebellar cortex and nuclei in spinocerebellar ataxia type 6 (SCA6), which is thought to primarily the cerebellar cortex, and SCA3 and FRDA, which affect primarily the cerebellar nuclei [41] .
In summary, SWI imaging allows to visualize dentate nuclei on individual scans. This has the diagnostic potential to reveal atrophy of the cerebellar nuclei in patients with cerebellar degeneration. Furthermore, lesion-symptom mapping is possible on the level of subdivisions of the dentate nuclei. Ultra-high-field MRI makes reliable fMRI studies of the dentate nuclei possible. In current studies we try to extend fMRI studies to the level of interposed nuclei using an eyeblink conditioning paradigm. Ultra-high field fMRI will be a helpful tool to understand the interactions between the cerebellar cortex and nuclei in future studies in healthy subjects and patients with cerebellar disease.
High Field Magnetic Resonance Spectroscopy in Movement Disorders: Biomarker and Surrogate Marker Potential (Gülin Öz)
Proton magnetic resonance spectroscopy ( 1 H MRS) enables the non-invasive quantification of a multitude of neurochemicals in selected brain regions at high and ultra-high fields [50, 51] . The neurochemicals that can be reliably quantified at 3 tesla (T) and higher fields include neurotransmitters, such as glutamate and γ-aminobutyric acid (GABA), antioxidants glutathione and ascorbate, and other important metabolites such as glutamine, in addition to those that are reliably quantified at 1.5 T, namely N-acetylaspartate (NAA), creatine, choline and, depending on acquisition parameters, myo-inositol and lactate. These "neurochemical profiles" are characteristic of brain regions [50] and may provide markers of onset, progression and reversal of pathology in affected brain regions in many neurological diseases [52] including movement disorders. The need for such non-invasive biomarkers of cerebral and cerebellar disease is particularly urgent in the area of preclinical and clinical trials for neurodegenerative diseases because they are slowly progressive, show substantial phenotypic variability and therefore typically necessitate long clinical trials with large sample sizes. In addition, clinical outcome measures that are routinely used in such trials do not distinguish symptomatic from disease-modifying effects of drugs. A number of recent studies focused on validating such in vivo markers of neurodegeneration in spinocerebellar ataxias (SCAs), hereditary movement disorders that cause atrophy and dysfunction of the cerebellum and in many cases also the brainstem. An ability to detect neurochemical alterations in SCA1, even in spectra from individual patients, was demonstrated first at 4 T [53] (Fig. 3) and recently also at the widely available 3 T platform [54] . In addition, significant correlations between the levels of select neurochemicals, namely the neuronal marker NAA, the putative gliosis marker myo-inositol and the neurotransmitter glutamate, and scores on the validated Scale for the Assessment and Rating of Ataxia (SARA) were observed [53] , demonstrating that the neurochemical levels reflect clinical status in SCA1. Furthermore, MRS has shown potential to distinguish different SCA genotypes with similar clinical presentation [55] .
Parallel studies with mouse models of SCA1 demonstrated that neurochemical levels measured by 1 H MRS are sensitive to pre-symptomatic and progressive pathological changes in the cerebellum [56] . Interestingly, the same neurochemicals that reflected the clinical status in patients with SCA1 (NAA, myo-inositol, glutamate) were also those that showed the strongest correlations with semi-quantitative pathology measures in the mouse model, indicating these as robust markers of the neurodegenerative process [56] . Later, studies with a conditional transgenic SCA1 model demonstrated the sensitivity of 1 H MRS measured neurochemical levels to disease reversal. Namely, upon suppression of transgene expression in this model, both the cerebellar pathology and abnormal neurochemical levels returned towards normal [57] . Finally, studies with a knock-in SCA1 model that displays milder cerebellar pathology than the transgenic line used in prior studies showed that neurochemical alterations can be detected prior to overt pathology in SCA1 [58] . To summarize, 1) 1 H MRS detects parallel neurochemical alterations in patients with SCA1 and SCA1 mouse models, 2) the same neurochemicals (NAA, myo-inositol, glutamate) reflect clinical status and pathological progression in SCA1, 3) neurochemical alterations are detectable prior to ataxia onset and overt pathology, and 4) reversal of neurochemical alterations with treatment is detectable by MRS.
The utility of MRS markers to detect neurochemical alterations and treatment response was also shown in Parkinson's disease (PD), the most common movement disorder. Early involvement of caudal brainstem in PD, even prior to the characteristic degeneration of nigrostriatal dopaminergic neurons, was suggested about 10 years ago based on detailed pathological investigations [59] and has been gaining wide acceptance. Motivated by this work, neurochemical alterations in the brainstem and striatum in early-moderate stage PD were recently investigated at the ultra-high field of 7 T. This study uncovered an elevation in the inhibitory neurotransmitter GABA in the pons [60] , in addition to elevated striatal GABA levels previously shown in postmortem investigations [61] . A more pronounced GABA elevation in the pons than in the putamen was consistent with an earlier involvement of the lower brainstem in the disease pathology. Therefore, the altered GABAergic tone demonstrated by MRS in the lower brainstem and striatum in early-moderate PD may underlie disease pathogenesis and may provide a biomarker for disease staging. Another recent study focused on a potentially useful antioxidant therapy in PD. Reductions in the levels of the major antioxidant glutathione (GSH) were reported in PD [62] , indicating the involvement of oxidative stress in the pathophysiology of the disease. In a pilot investigation, ultrahigh field MRS was used to monitor increases in brain GSH levels in patients with PD and healthy controls in response to a single, intravenous administration of N-acetylcysteine, a known precursor to GSH [63] . This study demonstrated the potential utility of MRS for monitoring treatment response by noninvasively measuring antioxidant levels in the brain.
The importance of spectral quality for the robustness of the above findings and reliable neurochemical quantification cannot be overemphasized. Thus, in all the above cited studies, in house developed, state-of-the art MRS methods were utilized. The critical need for standardization of MRS methodology for robust clinical applications was recently emphasized and the feasibility of implementing advanced MRS methods on clinical scanners was demonstrated in a multi-site setting in a recent consensus effort [52] .
Autism, Neural Timing, and the Cerebellum (James Ashe and Khalaf Bushara)
Autism is a severe developmental disorder characterized by abnormal social interaction, impaired language use and development, stereotypical repetitive movements, and resistance to change. It is remarkable that there is as yet no consensus on the neurological basis of this disorder first described in 1943 but now affecting more than 1 in every 100 children in the United States or in Europe. Although abnormalities have been documented in many different regions of the brain in those who died with this disorder, the most common abnormality has been a 30-40 % reduction in the population of Purkinje cells in lobules VI and VII of the cerebellum. It is not immediately obvious based on the conventional understanding of cerebellar physiology how disrupting its function might lead to the types of behavioral disturbances in autism. Welsh and colleagues [64] have provided a possible solution to this dilemma by proposing that disruption of a timing signal within the olivo-cerebellar circuit in infancy might lead to abnormal development of motor, cognitive and emotional processing [65] .
There is compelling evidence from experiments in vertebrate animals over a period of 40 years that cells in the inferior olive provide a rhythmic, synchronous output signal of [8] [9] [10] [11] [12] [13] Hz that is conveyed via climbing fibres to the Purkinje cells to produce complex spikes. Despite these data there has been skepticism about the role and importance of a rhythmic signal generated in the inferior olive primarily because the few experiments that had addressed the issue in non-human primates have been either inconclusive or unsupportive depending on one's perspective. We have recently demonstrated using functional neuroimaging in human subjects that the inferior olive is activated during the perception of the temporal [66] but not the non-temporal features [67] of changing visual stimuli. Furthermore, the sensitivity of the inferior olive to changes in stimulus timing is independent of awareness [68] , which suggests that this structure may contribute to the temporal properties that underlie classical conditioning and implicit learning.
We believe that lesions of the olivo-cerebellum either prenatally or in early infancy may disrupt the neural processing of temporal information and lead to the abnormalities of motor, cognitive and emotional behavior in autism. Our next step in exploring this hypothesis is to attempt to reproduce in mice some of the behavioral abnormalities characteristic of autism by genetically engineering mice to produce focal ablations of populations of Purkinje cells in utero.
